ask="31.50"
ask_size="500"
average_daily_volume="299092"
bid="N/A"
bid_size="N/A"
book_value="3.79"
change="-0.76"
change_from_200_day_moving_average="1.30"
change_from_50_day_moving_average="-2.60"
change_from_52_week_high="-6.21"
change_From_52_week_low="11.47"
change_in_percent="-2.88%"
close="25.59"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.07"
ebitda="-37.24M"
eps_estimate_current_year="-2.36"
eps_estimate_next_quarter="-0.54"
eps_estimate_next_year="-3.03"
ex_dividend_date="N/A"
float_shares="14358000"
high="26.35"
high_52_weeks="31.80"
last_trade_date="2/2/2017"
last_trade_price="25.59"
last_trade_size="6617"
last_trade_time="4:00pm"
low="25.42"
low_52_weeks="14.12"
market_capitalization="548.44M"
moving_average_200_day="24.29"
moving_average_50_day="28.19"
name="Aclaris Therapeutics
Inc."
notes="N/A"
one_year_target_price="38.17"
open="26.33"
pe_ratio="N/A"
peg_ratio="-0.19"
percent_change_from_200_day_moving_average="+5.36%"
percent_change_from_50_day_moving_average="-9.22%"
percent_change_from_52_week_high="-19.53%"
percent_change_from_52_week_low="+81.23%"
previous_close="26.35"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.96"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21432000"
short_ratio="6.03"
stock_exchange="NMS"
symbol="ACRS"
volume="150961"
weeks_range_52="14.12 - 31.80"
